• 1
    Bochenek WJ, Peters S, Fraga PD, et al. Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies. Helicobacter 2003; 8: 62642.
  • 2
    Graham DY. What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates. Dig Dis Sci 2002; 47: 166578.
  • 3
    Graham DY, Agrawal NM, Campbell DR, et al. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. Arch Int Med 2002; 162: 16975.
  • 4
    Park CY, Cho YK, Kodama T, et al. New serological assay for detection of putative Helicobacter pylori virulence factors. J Clin Microbiol 2002; 40: 47356.
  • 5
    Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BMJ 1999; 318: 5936.
  • 6
    Laine L. GI medical co-therapy use in 14,001 patients switching from chronic traditional NSAID therapy to chronic coxib therapy. Gastroenterology 2002; 122: A52 (Abstract).
  • 7
    Laine L, Von Allmen H, Henderson SC. GI healthcare resource use in 6009 patients switching from chronic NSAID to COX-2 specific inhibitor therapy and the effect of prior PPI use. Gastroenterology 2003; 124(Suppl. 1): A108 (Abstract).
  • 8
    Chan FK, Chung SC, Suen BY, et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001; 344: 96773.
  • 9
    Lai KC, Lam SK, Chu KM, et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 2002; 346: 20338.